PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22821666-10	2013	In guinea pig rectal myenteric ganglia, alpha-synuclein- and VAChT-immunoreactivity coexisted in 15 +- 1.4% of biotinamide-labeled extrinsic varicosities; only 1 +- 0.3% of biotinamide-labeled extrinsic varicosities contained alpha-synuclein-immunoreactivity without VAChT-immunoreactivity.	biotinamide	111-122	synuclein alpha	Homo sapiens	40-55	
22821666-10	2013	In guinea pig rectal myenteric ganglia, alpha-synuclein- and VAChT-immunoreactivity coexisted in 15 +- 1.4% of biotinamide-labeled extrinsic varicosities; only 1 +- 0.3% of biotinamide-labeled extrinsic varicosities contained alpha-synuclein-immunoreactivity without VAChT-immunoreactivity.	biotinamide	111-122	solute carrier family 18 member A3	Homo sapiens	61-66	
22821666-10	2013	In guinea pig rectal myenteric ganglia, alpha-synuclein- and VAChT-immunoreactivity coexisted in 15 +- 1.4% of biotinamide-labeled extrinsic varicosities; only 1 +- 0.3% of biotinamide-labeled extrinsic varicosities contained alpha-synuclein-immunoreactivity without VAChT-immunoreactivity.	biotinamide	173-184	synuclein alpha	Homo sapiens	40-55	
22821666-10	2013	In guinea pig rectal myenteric ganglia, alpha-synuclein- and VAChT-immunoreactivity coexisted in 15 +- 1.4% of biotinamide-labeled extrinsic varicosities; only 1 +- 0.3% of biotinamide-labeled extrinsic varicosities contained alpha-synuclein-immunoreactivity without VAChT-immunoreactivity.	biotinamide	173-184	solute carrier family 18 member A3	Homo sapiens	61-66